Showing 1 - 8 results of 8 for search 'Marie-Émilie Dourthe', query time: 0.03s
Refine Results
-
1
CAR T-cells for T-cell acute lymphoblastic leukemia by Marie Emilie Dourthe, André Baruchel
Published 2024-06-01
Article -
2
Real-world Experience of Approved Chimeric Antigen Receptor T-cell Therapies Compared to Clinical Trials Data by Jérôme Lambert, Roberta Di Blasi, Florence Rabian, Marie-Emilie Dourthe, André Baruchel, Catherine Thiéblemont, Nicolas Boissel, Vincent Levy, Marie-Quitterie Picat, Sylvie Chevret
Published 2023-06-01
Article -
3
Impact of T-cell Receptor Status on Mutational Landscape and Outcome in T-ALL by Marie Emilie Dourthe, Lucien Courtois, Guillaume P. Andrieu, Mathieu Simonin, Aurore Touzart, Ludovic Lhermitte, Arnaud Petit, Nicolas Boissel, André Baruchel, Vahid Asnafi, Elizabeth Macintyre
Published 2023-04-01
Article -
4
S106: METABOLIC PLASTICITY REVEALS A TARGETABLE VULNERABILITY IN LEUKEMIA by Guillaume Andrieu, Mathieu Simonin, Aurélie Cabannes-Hamy, Etienne Lengliné, Ambroise Marçais, Marie-Emilie Dourthe, Alexandre Theron, Nicolas Boissel, Hervé Dombret, Philippe Rousselot, Olivier Hermine, Vahid Asnafi
Published 2023-08-01
Article -
5
P321: TNF-MEDIATED CELL DEATH: AN ACTIONABLE TARGET FOR IMMUNOTHERAPY IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA by Marie-Emilie Dourthe, Etienne Lengline, Guillaume Charbonnier, Mehdi Latiri, Chaimae Saji, Agata Cieslak, Mathieu Simonin, Norbert Ifrah, Hervé Dombret, Olivier Hermine, Nicolas Boissel, André Baruchel, Jacques Ghysdael, Elizabeth Macintyre, Christine Tran-Quang, Guillaume Andrieu, Vahid Asnafi
Published 2023-08-01
Article -
6
Harnessing the MYB-dependent TAL1 5’super-enhancer for targeted therapy in T-ALL by Charlotte Smith, Aurore Touzart, Mathieu Simonin, Christine Tran-Quang, Guillaume Hypolite, Mehdi Latiri, Guillaume P. Andrieu, Estelle Balducci, Marie-Émilie Dourthe, Ashish Goyal, Françoise Huguet, Arnaud Petit, Norbert Ifrah, André Baruchel, Hervé Dombret, Elizabeth Macintyre, Christoph Plass, Jacques Ghysdael, Nicolas Boissel, Vahid Asnafi
Published 2023-01-01
Article -
7
TREC mediated oncogenesis in human immature T lymphoid malignancies preferentially involves ZFP36L2 by Estelle Balducci, Thomas Steimlé, Charlotte Smith, Patrick Villarese, Mélanie Feroul, Dominique Payet-Bornet, Sophie Kaltenbach, Lucile Couronné, Ludovic Lhermitte, Aurore Touzart, Marie-Emilie Dourthe, Mathieu Simonin, André Baruchel, Hervé Dombret, Norbert Ifrah, Nicolas Boissel, Bertrand Nadel, Elizabeth Macintyre, Agata Cieslak, Vahid Asnafi
Published 2023-07-01
Article -
8
Oncogenetic landscape and clinical impact of IDH1 and IDH2 mutations in T-ALL by Mathieu Simonin, Aline Schmidt, Christophe Bontoux, Marie-Émilie Dourthe, Etienne Lengliné, Guillaume P. Andrieu, Ludovic Lhermitte, Carlos Graux, Nathalie Grardel, Jean-Michel Cayuela, Françoise Huguet, Isabelle Arnoux, Stéphane Ducassou, Elizabeth Macintyre, Virginie Gandemer, Hervé Dombret, Arnaud Petit, Norbert Ifrah, André Baruchel, Nicolas Boissel, Vahid Asnafi
Published 2021-05-01
Article